Our findings show that an ABI of 1.3 or more predicts for both
overall and cardiovascular mortality, and an ABI of less than 0.9 predicts for
cardiovascular mortality in CKD and haemodialysis patients. Screening
patients with chronic renal failure by means of ABI may help to identify a
high-risk group for increased mortality
Ankle-brachial index (ABI) was shown to be
an important screening method for
cardiovascular mortality in patients with
advanced renal disease. An ABI in excess
of 1.3 implicated higher overall and
cardiovascular mortality; where an ABI of
less than 0.9 predicted higher
cardiovascular mortality in CKD and
hemodialysis patients